VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CRMDCorMedix Inc.
$8.67$680M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCRMDEarnings History

CRMD logoCorMedix Inc. (CRMD) Earnings History

Profitable

18 years of earnings data (2008–2025) · Positive TTM net income

TTM Net Income
$181M
● Profitable
TTM EPS (Diluted)
$1.95
Per share, diluted
YoY EPS Growth
+780.0%
Excellent
Net Margin
52.3%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin48.2%
Gross Margin88.5%
Return on Equity66.6%
Return on Assets34.5%
Record Annual Net Income$163MFY2025
Record Quarterly EPS$9.77Q1 2023
Consecutive Profitable Years1years
Q1 2026
Net Income$39M
EPS (Diluted)$0.42
YoY Growth+780.0%Excellent
QoQ Growth+175.3%Excellent

Loading earnings history...

CorMedix Inc. (CRMD) Earnings Overview

As of June 22, 2026, CorMedix Inc. (CRMD) reported trailing twelve-month net income of $181M, reflecting +780.0% year-over-year growth. The company earned $1.95 per diluted share over the past four quarters, with a net profit margin of 52.3%.

Looking at the long-term picture, CRMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $163M in fiscal 2025, representing a new all-time high.

CorMedix Inc. maintains industry-leading profitability with a gross margin of 88.5%, operating margin of 48.2%, and net margin of 52.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including NKTR (-$158M net income, -297.1% margin), HALO ($349M net income, 22.7% margin), PRAX (-$327M net income), CRMD has outperformed on profitability metrics. Compare CRMD vs NKTR →

CRMD Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
CRMD logoCRMDCurrent
$181M$1.9552.3%66.6%+780.0%—
NKTR logoNKTR
-$158M$-6.39-297.1%-217.9%-12.1%
HALO logoHALO
$349M$2.8422.7%153.6%-25.4%
PRAX logoPRAX
-$327M$-11.31--45.8%-32.0%
ACAD logoACAD
$376M$2.1836.5%39.9%+68.4%
SUPN logoSUPN
-$29M$-0.50-5.4%-3.7%-151.5%
Best in group
Lowest in group

CRMD Historical Earnings Data (2008–2025)

18 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$163M+1009.4%$150M$2.0452.3%48.2%
2024-$18M+61.3%-$22M$-0.30-41.2%-51.4%
2023-$46M-56.0%-$49M$-0.91--
2022-$30M-5.3%-$31M$-0.74-45409.9%-46819.9%
2021-$28M-28.1%-$29M$-0.75-14774.7%-15417.5%
2020-$22M-34.0%-$27M$-0.77-9207.7%-11378.4%
2019-$16M+38.8%-$21M$-0.68-5801.3%-7416.3%
2018-$27M+18.7%-$27M$-1.51-6242.4%-6250.4%
2017-$33M-33.9%-$33M$-2.99-10023.4%-9997.4%
2016-$25M-35.5%-$25M$-3.25-10996.5%-11048.8%
2015-$18M+11.1%-$17M$-2.90-8655.4%-7925.6%
2014-$20M-123.9%-$9M$-4.77-10806.3%-4703.3%
2013-$9M-166.6%-$5M$-3.30-456654.9%-245769.8%
2012-$3M+49.0%-$3M$-1.50--
2011-$7M+38.5%-$7M$-2.94--
2010-$11M-34.3%-$9M$-5.76--
2009-$8M+9.7%-$6M$-47.40--
2008-$9M--$5M$-53.42--

Download Data

Export CRMD earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

18+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CRMD — Frequently Asked Questions

Quick answers to the most common questions about buying CRMD stock.

What is CRMD earnings per share (EPS)?

CRMD trailing twelve-month (TTM) diluted EPS is $1.95, reflecting +780.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2008 to 2025 is available in the table on this page.

What is CorMedix Inc.'s net income?

CorMedix Inc. (CRMD) trailing twelve-month net income is $181M as of 2025. Earnings grew +780.0% year-over-year.

Is CRMD profitable?

Yes, CRMD is profitable with a TTM net income of $181M and a net profit margin of +52.3%.

What is CRMD's earnings growth rate?

CRMD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2008 to 2025.

What are CRMD's profit margins?

CorMedix Inc. net profit margin is +52.3%, operating margin is +48.2%, and gross margin is +88.5%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +66.6%.

Is CRMD growing earnings?

Yes, CRMD earnings are accelerating — EPS growth of +780.0% exceeds the 5-year CAGR of N/A. TTM net income reached $181M. Earnings momentum is strengthening.

What was CRMD's best earnings year?

CorMedix Inc.'s highest annual net income on record is $163M, achieved in fiscal year 2025. Earnings history on this page spans 2008 to 2025 and includes all annual and quarterly figures.

What were CRMD's earnings last quarter?

CRMD's most recent reported quarter was Q1 2026. Net income was $39M with diluted EPS of $0.42. For a full breakdown of all quarters, see the quarterly earnings table on this page.

CRMD Earnings Over Time (2008–2025)

Net income & EPS — annual and quarterly view